{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:51:14Z","timestamp":1793911874655,"version":"4.8.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Biliary tract carcinomas (BTCs) are relatively rare but lethal primary malignant tumors derived from the biliary tract system. The burden of BTCs varies according to sex, age, region, and country, but limited attention has been paid to the burden of BTCs. We sought to explore the up-to-date data from the Global Burden of Disease Study (GBD) and expand findings by accessing the demographic features of BTC disease burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using the latest data from the GBD 2021, we evaluated and analyzed the distributions and patterns of BTC disease burden in various age groups, sexes, regions, and countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The number of incident cases, deaths, and disability-adjusted life-years (DALYs) tended to increase and peaked at 216,770 (95% uncertainty interval [UI]: 181,890\u2013245,240), 171,960 (95% UI: 142,350\u2013194,240), and 3,732,100 (95% UI: 3,102,900\u20134,317,000) person-years, respectively, in 2021. However, the average global age-standardized rates (ASRs) of incident cases, deaths, and DALYs shrunk by \u221211.46% (95% UI: \u221221.91 to 3.35%), \u221224.09% (95% UI: \u221233.19 to 16.88%), and \u221226.25% (95% UI: \u221235.53 to 18.36%), respectively, from 1990 to 2021. Meanwhile, the male\/female ratio (male per 100 female) of incidence, deaths, and DALYs changed from 76.40, 75.41, and 74.72 to 86.89, 79.11, and 82.29, respectively. In 2021, the highest number of incident cases, deaths, and DALYs occurred in East Asia. The top three highest incidences, deaths, and DALYs were observed in China, India, and Japan, and the highest ASRs were observed in Chile in 2021. Analysis of the Human Development Index along with disease burden estimates of BTCs also suggests that the burden of the disease is related to the level of comprehensive development of the society.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study provided a comprehensive comparison of differences in the burden of disease across populations and over time, and further presented evidence concerning the formulation of prevention and control policies and etiologic studies for BTCs and proposed logical hypotheses to investigate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003395","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:03:18Z","timestamp":1734393798000},"page":"3117-3125","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Disease burden of biliary tract cancer in 204 countries and territories, 1990\u20132021: A comprehensive demographic analysis of the Global Burden of Disease Study 2021"],"prefix":"10.1097","volume":"137","author":[{"given":"Xuheng","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangmei","family":"Liu","sequence":"additional","affiliation":[{"name":"National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[{"name":"National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbing","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"},{"name":"Department of General Surgery, Jiading Branch, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201800, China"},{"name":"Shanghai Key Laboratory of Systems Regulation and Clinical Translation for Cancer, Shanghai 200127, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maigeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"},{"name":"Department of General Surgery, Jiading Branch, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201800, China"},{"name":"Shanghai Key Laboratory of Systems Regulation and Clinical Translation for Cancer, Shanghai 200127, China"},{"name":"State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai 200127, China"},{"name":"Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO Clinical Practice Guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J Clin Oncol"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R5-20250602","first-page":"243","article-title":"Guideline for the diagnosis and treatment of gallbladder carcinoma (2019 edition) (in Chinese)","volume":"58","year":"2020","journal-title":"Chin J Surg"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811\u00a0subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10654-011-9636-8","article-title":"Declining rates of hepatocellular carcinoma in urban Shanghai: Incidence trends in 1976-2005","volume":"27","author":"Gao","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.gastro.2023.05.050","article-title":"Global burden of digestive diseases: A systematic analysis of the Global Burden of Diseases Study, 1990 to 2019","volume":"165","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371\u00a0diseases and injuries in 204 countries and territories and 811\u00a0subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: The GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1470-2045(17)30438-2","article-title":"The TNM classification of malignant tumours\u2013Towards common understanding and reasonable expectations","volume":"18","author":"O\u2019Sullivan","year":"2017","journal-title":"Lancet Oncol"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354\u00a0diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1008953201688","article-title":"Partitioning linear trends in age-adjusted rates","volume":"11","author":"Hankey","year":"2000","journal-title":"Cancer Causes Control"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811\u00a0subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"1384314","DOI":"10.3389\/fmed.2024.1384314","article-title":"Global, regional, and national burden and trends analysis of gallbladder and biliary tract cancer from 1990 to 2019 and predictions to 2030: A systematic analysis for the Global Burden of Disease Study 2019","volume":"11","author":"Su","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"941284","DOI":"10.3389\/fpubh.2022.941284","article-title":"Chinese and global burdens of gastrointestinal cancers from 1990 to 2019","volume":"10","author":"Xie","year":"2022","journal-title":"Front Public Health"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/jgh.15859","article-title":"Global burden of gallbladder and biliary diseases: A systematic analysis for the Global Burden of Disease Study 2019","volume":"37","author":"Li","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968\u20131998","volume":"48","author":"Taylor-Robinson","year":"2001","journal-title":"Gut"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s12094-021-02573-1","article-title":"SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)","volume":"23","author":"G\u00f3mez-Espa\u00f1a","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.22756","article-title":"Family history of gallstones and the risk of biliary tract cancer and gallstones: A population-based study in Shanghai, China","volume":"121","author":"Hsing","year":"2007","journal-title":"Int J Cancer"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0140-6736(24)00550-6","article-title":"Global fertility in 204 countries and territories, 1950\u20132021, with forecasts to 2100: A comprehensive demographic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Bhattacharjee","year":"2024","journal-title":"Lancet"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ags3.12434","article-title":"Essential updates 2019\/2020: Surgical treatment of gallbladder cancer","volume":"5","author":"Matsuyama","year":"2021","journal-title":"Ann Gastroenterol Surg"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cgh.2024.01.051","article-title":"Global epidemiology of gallstones in the 21st century: A systematic review and meta-analysis","volume":"22","author":"Wang","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cgh.2022.04.010","article-title":"The natural history of asymptomatic gallstones: A longitudinal study and prediction model","volume":"21","author":"Morris-Stiff","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R33-20250602","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","article-title":"Worldwide distribution, associated factors, and trends of gallbladder cancer: A global country-level analysis","volume":"521","author":"Huang","year":"2021","journal-title":"Cancer Lett"},{"key":"R35-20250602","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R36-20250602","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.puhe.2021.12.002","article-title":"Trend analysis and risk of gallbladder cancer mortality in China, 2013\u20132019","volume":"203","author":"Nie","year":"2022","journal-title":"Public Health"},{"key":"R37-20250602","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cncr.22815","article-title":"Recent trends of gallbladder cancer in Japan: An analysis of 4,770 patients","volume":"110","author":"Kayahara","year":"2007","journal-title":"Cancer"},{"key":"R38-20250602","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1158\/1055-9965.EPI-05-0032","article-title":"Aspirin use and risk of biliary tract cancer: A population-based study in Shanghai, China","volume":"14","author":"Liu","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R39-20250602","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.bjc.6604047","article-title":"Gallstones and the risk of biliary tract cancer: A population-based study in China","volume":"97","author":"Hsing","year":"2007","journal-title":"Br J Cancer"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/CEJ.0000000000000758","article-title":"Descriptive epidemiology of biliary tract cancer incidence and geographic variation in Japan","volume":"32","author":"Makiuchi","year":"2023","journal-title":"Eur J Cancer Prev"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00535-024-02124-9","article-title":"Body mass index and survival among patients with advanced biliary tract cancer: A single-institutional study with nationwide data-based validation","volume":"59","author":"Takaoka","year":"2024","journal-title":"J Gastroenterol"},{"key":"R42-20250602","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ijc.34740","article-title":"Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019","volume":"154","author":"Yu","year":"2024","journal-title":"Int J Cancer"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:05:18Z","timestamp":1748876718000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":39,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003395","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"2024-06-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}